Markman Biologics
Markman Biologics has obtained a series of novel patents that pertain to Micro Resurfacing of Reconstructive tissue grafts.
Markman Biologics is active in the biotechnology, health care, medical, medical device space based in Western US, founded in 2017.
Markman Biologics is positioned in biotechnology, health care, medical, medical device, a segment that rewards a clear, focused offering.
The company is recorded as being based in Western US.
Its current recorded stage is Seed.
Its team size is recorded as c_00011_00050 employees.
It has disclosed roughly $223K in funding.
| Sector | Biotechnology, Health Care, Medical, Medical Device |
|---|---|
| Headquarters | Western US |
| Founded | 2017 |
| Employees | c_00011_00050 |
| Stage | seed |
| Total funding | $223,000 |
Website: markmanbiologics.com
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account